# Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck

> **NCT00233636** · PHASE2 · WITHDRAWN · sponsor: **AstraZeneca** · enrollment: 28 (—)

## Conditions studied

- Head and Neck Cancer
- Carcinoma, Squamous Cell

## Interventions

- **DRUG:** Iressa (Gefitinib)
- **PROCEDURE:** Radiotherapy

## Key facts

- **NCT ID:** NCT00233636
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 28 (—)
- **Last updated:** 2011-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233636, "Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00233636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*